AstraZeneca
We are excited to announce the first-ever Biology in Abstract Challenge. The initiative is sponsored by AstraZeneca, a global, science-led biopharmaceutical company. AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop, and deliver lifechanging medicines to patients. The Biology in Abstract Challenge is an open call to US-based artists to create abstract artwork expressing the science through which two medicines work together to fight cancer. Many of us have been impacted by cancer in some way; the Biology in Abstract Challenge aims to bring a new perspective to what can usually only be seen under a microscope.